KMG Chemicals (KMG) to Release Earnings on Monday

KMG Chemicals (NYSE:KMG) is scheduled to be releasing its earnings data after the market closes on Monday, December 11th. Analysts expect KMG Chemicals to post earnings of $0.75 per share for the quarter.

KMG Chemicals (NYSE:KMG) last issued its earnings results on Monday, October 16th. The specialty chemicals company reported $0.69 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.53 by $0.16. KMG Chemicals had a net margin of 7.09% and a return on equity of 17.45%. The company had revenue of $96.26 million for the quarter, compared to the consensus estimate of $96.00 million. The company’s quarterly revenue was up 27.8% compared to the same quarter last year. On average, analysts expect KMG Chemicals to post $3 EPS for the current fiscal year and $3 EPS for the next fiscal year.

Shares of KMG Chemicals (KMG) opened at $53.61 on Monday. The company has a market cap of $823.77, a price-to-earnings ratio of 23.62 and a beta of 0.55. The company has a quick ratio of 1.64, a current ratio of 2.52 and a debt-to-equity ratio of 3.01. KMG Chemicals has a 52 week low of $32.05 and a 52 week high of $61.10.

In other KMG Chemicals news, major shareholder David L. Hatcher sold 9,000 shares of the company’s stock in a transaction dated Thursday, September 7th. The shares were sold at an average price of $48.13, for a total transaction of $433,170.00. Following the transaction, the insider now directly owns 1,595,097 shares in the company, valued at approximately $76,772,018.61. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, major shareholder David L. Hatcher sold 3,000 shares of the company’s stock in a transaction dated Wednesday, September 13th. The shares were sold at an average price of $48.69, for a total transaction of $146,070.00. Following the transaction, the insider now owns 1,577,097 shares in the company, valued at $76,788,852.93. The disclosure for this sale can be found here. In the last quarter, insiders have sold 219,000 shares of company stock worth $11,564,130. 6.10% of the stock is owned by corporate insiders.

KMG has been the topic of several research reports. Zacks Investment Research downgraded shares of KMG Chemicals from a “buy” rating to a “hold” rating in a research report on Tuesday, August 15th. KeyCorp initiated coverage on shares of KMG Chemicals in a research report on Tuesday, November 21st. They set an “overweight” rating and a $63.00 price target on the stock. ValuEngine downgraded shares of KMG Chemicals from a “buy” rating to a “hold” rating in a research report on Friday. Finally, BidaskClub downgraded shares of KMG Chemicals from a “sell” rating to a “strong sell” rating in a research report on Saturday, August 12th. Two analysts have rated the stock with a sell rating, one has assigned a hold rating and two have issued a buy rating to the company. The company has an average rating of “Hold” and an average target price of $50.00.

COPYRIGHT VIOLATION WARNING: This news story was reported by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are accessing this news story on another domain, it was illegally stolen and republished in violation of international copyright laws. The legal version of this news story can be read at https://ledgergazette.com/2017/12/04/kmg-chemicals-kmg-to-release-earnings-on-monday.html.

About KMG Chemicals

KMG Chemicals, Inc manufactures, formulates and globally distributes specialty chemicals. The Company operates businesses selling electronic chemicals, industrial wood treating chemicals, and industrial valve lubricants and sealants. The Company operates through two segments: Electronic chemicals and Other chemicals.

Earnings History for KMG Chemicals (NYSE:KMG)

Receive News & Ratings for KMG Chemicals Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for KMG Chemicals Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply